Navigation Links
Telik Announces Third Quarter 2009 Financial Results
Date:11/13/2009

ik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA®, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA®, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at www.telik.com.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

                                    Telik, Inc.
                             Statements of Operations
                     (In thousands, except per share amounts)
                                    (Unaudited)

                                        Three Months Ended  Nine Months Ended
                                           September 30,      September 30,
                                           -------------      -------------
                                           2009     2008      2009      2008
                                           ----     ----      ----      ----
    Operating costs and expenses:
      Research and development            $3,416   $4,820   $10,428   $21,251
      General and administrative           2,759    2,822     8,845     8,008
      Restructuring costs                      -      199       951       199
                                             ---      ---       ---       ---
        Total operating costs and
         expenses                          6,175    7,841    2
'/>"/>
SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014  Over 200 patients, families, physicians ... to learn, interact and participate in the drive ... Lupus Trials Fair launched by the Lupus ... Lupus Foundation .  Attendees interacted directly with researchers ... experiences, ideas and needs and learning about more ...
(Date:9/15/2014)... 2014 Biomerics LLC, a leading provider ... announced its merger with Access Point Technologies and ... division was formed to provide next generation catheter ... structure heart, interventional radiology, interventional cardiology, and neurovascular ... will be led by Steve Berhow , ...
(Date:9/15/2014)... 2014 Chek Diagnostics, the U.S.-based manufacturer of ... point-of-care diagnostic products, has again been named to the ... companies in America. The Inc. 5000 ranking ... Chek Diagnostics earned its place on the list by ... 2013. For Chek Diagnostics, who appears on ...
Breaking Medicine Technology:Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3
... landmark trial provide important insight for physicians in treating ... Corporation (NYSE: BSX ) today welcomed the ... this week,s issue of the New England Journal of ... Cardiovascular Research Foundation with research grant support from Boston ...
... over linezolid in resistance acquisition by Staph aureus ... meetingSAN DIEGO, Calif., May 6 Trius Therapeutics, ... the treatment of serious bacterial infections, announced today ... lead program, torezolid (TR-701), will be presented in ...
Cached Medicine Technology:Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 2Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 3Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 4Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 5Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 2Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 3
(Date:9/15/2014)... Transvaginal mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) ... in the federal multidistrict litigation now underway in U.S. ... LLP reports. According to documents filed in the proceeding, ... that provides for the severance of several actions in ... affected plaintiffs has objected to severance of the cases. ...
(Date:9/15/2014)... to recent studies, approximately one out of every 40 individuals ... responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that ... University of Missouri have made a recent breakthrough with the ... in animal models of the disease. In April, a patent ... "The strategy our lab is using to fight SMA is ...
(Date:9/15/2014)... Alto, CA (PRWEB) September 15, 2014 ... anniversary since its founding in 2007. To mark the ... local community for supporting the village and helping it ... provides a safe, secure and fun community for seniors. ... to the community and live in their own homes. ...
(Date:9/15/2014)... (HealthDay News) -- Births of multiple babies cost more ... singleton births, researchers report. The researchers suggest that ... (IVF) could ease some of that burden. Over ... tandem with births to older mothers and use of ... of New South Wales, Australia. Their study, published ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Providing ... Cherry Bekaert LLP (“the Firm”) is ... as a Director with the Firm’s Litigation ... 25 years of experience, Wolf will assist clients ... advisory and transactional advisory matters. He will also ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 3
... to blood, bladder and ovarian malignancies, researchers say, , , ... at a tumor,s or patient,s genetics can provide important, ... So say scientists who outlined their research Tuesday in ... annual meeting, in Denver. , "This is an interesting ...
... Wainwright Bank & Trust Company (Nasdaq: WAIN ... complex New Markets Tax Credit financing structure for Hope House, ... job training and job placement for recovering alcoholics and substance ... Credit Allocation (as the controlling entity of AI Wainwright LLC) ...
... April 22 TOPICA Pharmaceuticals today announced the enrollment ... luliconazole for the treatment of tinea pedis (athlete,s foot). ... one of the most potent and broad spectrum molecules ... the potential to provide physicians and patients with a ...
... Misonix, Inc. (Nasdaq: MSON ), a developer ... Europe is used for the ablation of tumors and ... a definitive, 5-year distribution agreement with DTL Medical srl, ... the agreement, DTL will market the Sonablate(R) 500 High ...
... today that it will host its annual investor and analyst day on Thursday, ... Braintree, Massachusetts.The agenda for the meeting includes:, , ... Plasma Market Trends , ... R&D Progress , , , , ...
... combination of herbal ingredients contained in the anti-oxidant LiverLife ... reduce allergic responses in children with Autism Spectrum Disorder.LAGUNA ... brunt of the chemical age, accumulating toxins that weaken ... LiverLife(TM) significantly lowers the immune response ...
Cached Medicine News:Health News:Gene Studies Reveal Cancer's Secrets 2Health News:Gene Studies Reveal Cancer's Secrets 3Health News:Gene Studies Reveal Cancer's Secrets 4Health News:Gene Studies Reveal Cancer's Secrets 5Health News:Wainwright Bank Provides $10 Million in New Markets Tax Credits and $7.4 Million in Financing to Hope House 2Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 2Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 3Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 2Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 3Health News:Haemonetics Sets Date for Investor/Analyst Meeting 2Health News:BioRay's LiverLife Reduces Food Allergies in Autistic Children 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: